Zenex Animal Health Acquires Majority Stake in VievePharm

Zenex Animal Health India Acquires Majority Stake in VievePharm

Zenex Animal Health India, a leading animal health company, has acquired a majority stake in VievePharm, a Netherlands-based specialist in natural animal nutrition, for an undisclosed sum. This strategic move expands Zenex's portfolio of natural and herbal animal health products and provides a manufacturing and sales base in Western Europe.

VievePharm, headquartered in Enter, Netherlands, has expertise in phytogenic formulations for the livestock, equine, and pet care markets. The company's advanced bolus technology, used to deliver minerals, vitamins, and udder health support, will be integrated into Zenex's broader product offering globally. This integration is expected to enhance Zenex's ability to offer holistic, science-backed solutions to its customers.

The acquisition comes as the European Union's Farm to Fork Strategy targets a 50% reduction in veterinary antibiotic sales by 2030 compared to 2018 levels. Zenex expects this trend to benefit its combined naturals portfolio. The company has operations across Asia, Africa, and parts of the CIS region and plans to accelerate its entry into Western European markets using VievePharm's established distribution network.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Key Developments:

• Zenex Animal Health India acquires majority stake in VievePharm
• Acquisition expands Zenex's portfolio of natural and herbal animal health products
• VievePharm's expertise in bolus technology to be integrated into Zenex's product offering
• Expected to enhance Zenex's ability to offer holistic, science-backed solutions